Previous work has studied the role of Nlrp3 and another member of the NLR inflammasome family, Nlrp6, in the context of nonalcoholic fatty liver disease (NAFLD) [46]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.